FDA Bans OTC Inhalers Because CFCs Hurt the Ozone

September 23, 2011
The Food and Drug Administration has decided that all those wheezing asthma sufferers can afford to shell out a little more for their inhalers and have banned all over the counter puffers. They’ll have to pay more for “prescription-only alternatives” because the OTC brands contain cloro-florocarbons, which damage the ozone:

The action is part of an agreement signed by the U.S. and other nations to stop using substances that deplete the ozone layer, a region in the atmosphere that helps block harmful ultraviolet rays from the Sun.
But the switch to a greener inhaler will cost consumers more. Epinephrine inhalers are available via online retailers for around $20, whereas the alternatives, which contain the drug albuterol, range from $30 to $60.
The FDA finalized plans to phase out the products in 2008 and currently only Armstrong Pharmaceutical’s Primatene mist is available in the U.S. Other manufacturers have switched to an environmentally-friendly propellant called hydrofluoroalkane. Both types of inhalers offer quick-relief to symptoms like shortness of breath and chest tightness, but the environmentally-friendly inhalers are only available via prescription.

There are only 1-2 million people using Primatene. I can’t imagine that would be that big of an impact on the ozone layer. Nonetheless, if you suffer from asthma, your medical bill is about to increase, possibly double or triple.

Wheeeeeeez Wheeeeeeez Wheeeeeeez ….but at least I’m not hurting the environment


The FDA’s Disturbing Propaganda

June 22, 2011

…I_heard_about_this… this morning and I was afraid to look. I should of, I bet I get a lot of hits for these fucking puke disgusting images. Really… I’m a smoker and it is disturbing. Right now I’m on those free nicotine patches from…
New York Smoke Free. That is if you are in N.Y.State. It is pretty good because I save a lot of money. I mean… who can turn down free Nicotine… Shit! h/t Conservative Compendium

of Boobies And Death Panels. oh noes… they were real?

December 8, 2010

The first battle in the death panel wars is underway and the winner will be declared on December 17.  On that day, the Food and Drug Administration will determine whether insurance and Medicare should provide breast cancer patients and their doctors the option of using Avastin — a late-stage cancer drug that has been proven to extend life.  Should the FDA deny coverage for the drug because of its cost, it will be apparent that Krugman and his ilk are winning to battle to ration care in America.  Rest assured we are watching the outcome.

boobies via midgetquest.blogspot.com